Although functional receptors for thromboxane A2 and prostaglandin H-2
(TxA2/PGH2) have been identified in platelets and vascular smooth mus
cle cells, receptor-mediated events in human endothelial cells stimula
ted by these endoperoxides have not been shown. Using cultured endothe
lial cells harvested from human umbilical or saphenous veins, we measu
red the effect of the TxA2 mimetic U46619 on mobilization of cytoplasm
ic calcium ([Ca2+]i), as well as release of prostacyclin and expressio
n of the proto-oncogene c-fos, intracellular events that have been lin
ked to [Ca2+]i rise in stimulated endothelial cells. Addition of U4661
9 to confluent fura 2-loaded endothelial cells caused a concentration-
dependent rise in intracellular [Ca2+]i, with agonist concentrations o
f 300 nM producing a maximal [Ca2+]i rise. This [Ca2+]i rise was a uni
form response observed in all individual endothelial cells throughout
the monolayer, as shown by microspectrofluorimetric visualization. Sim
ilar effects were seen with a structurally dissimilar endoperoxide ana
logue, I-BOP, and with the naturally occurring endoperoxide PGH2. The
initial [Ca2+]i rise was not reduced when extracellular [Ca2+]i was ch
elated with EGTA, but a later ''plateau'' phase was eliminated. An ant
agonist of the receptor for TxA2/PGH2 (SQ29548) strongly inhibited [Ca
2+]i mobilization. Stimulation of endothelial cells with U46619 also t
ransiently increased expression of the proto-oncogene c-fos, as determ
ined by RNA hybridization, and induced a fivefold increase in prostacy
clin release. Thus, endoperoxides can stimulate human venous endotheli
al cells by means of TxA2/PGH2 receptors, whose occupancy can activate
intracellular events associated with functional changes.